These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 35772137)
1. Serum Claudin-5, but not Zonulin, May Be Associated with Obsessive-Compulsive Disorder. Kılıç F; Işık Ü; Kumbul Doğuç D Psychiatr Danub; 2022; 34(2):273-278. PubMed ID: 35772137 [TBL] [Abstract][Full Text] [Related]
2. Serum zonulin and claudin-5 levels in children with obsessive-compulsive disorder. Işık Ü; Aydoğan Avşar P; Aktepe E; Doğuç DK; Kılıç F; Büyükbayram Hİ Nord J Psychiatry; 2020; 74(5):346-351. PubMed ID: 31961248 [No Abstract] [Full Text] [Related]
3. Serum zonulin and claudin-5 levels in patients with bipolar disorder. Kılıç F; Işık Ü; Demirdaş A; Doğuç DK; Bozkurt M J Affect Disord; 2020 Apr; 266():37-42. PubMed ID: 32056901 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum zonulin and occludin levels in obsessive-compulsive disorder and the effect of major depressive disorder comorbidity. Zengil S; Laloğlu E Front Psychiatry; 2024; 15():1395235. PubMed ID: 39109367 [TBL] [Abstract][Full Text] [Related]
5. Serum zonulin and claudin-5 levels in patients with schizophrenia. Usta A; Kılıç F; Demirdaş A; Işık Ü; Doğuç DK; Bozkurt M Eur Arch Psychiatry Clin Neurosci; 2021 Jun; 271(4):767-773. PubMed ID: 32564127 [TBL] [Abstract][Full Text] [Related]
6. Serum zonulin and claudin-5 levels in children with attention-deficit/hyperactivity disorder. Aydoğan Avşar P; Işık Ü; Aktepe E; Kılıç F; Doğuç DK; Büyükbayram Hİ Int J Psychiatry Clin Pract; 2021 Mar; 25(1):49-55. PubMed ID: 32757874 [TBL] [Abstract][Full Text] [Related]
7. Zonulin-Dependent Intestinal Permeability in Children Diagnosed with Mental Disorders: A Systematic Review and Meta-Analysis. Asbjornsdottir B; Snorradottir H; Andresdottir E; Fasano A; Lauth B; Gudmundsson LS; Gottfredsson M; Halldorsson TI; Birgisdottir BE Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635367 [TBL] [Abstract][Full Text] [Related]
8. Relationship between severity of obsessive-compulsive symptoms and schizotypy in obsessive-compulsive disorder. Yamamoto H; Tsuchida H; Nakamae T; Nishida S; Sakai Y; Fujimori A; Narumoto J; Wada Y; Yoshida T; Taga C; Fukui K Neuropsychiatr Dis Treat; 2012; 8():579-83. PubMed ID: 23248572 [TBL] [Abstract][Full Text] [Related]
9. Zonulin and claudin-5 levels in multisystem inflammatory syndrome and SARS-CoV-2 infection in children. Kılıç AO; Akın F; Yazar A; Metin Akcan Ö; Topcu C; Aydın O J Paediatr Child Health; 2022 Sep; 58(9):1561-1565. PubMed ID: 35638118 [TBL] [Abstract][Full Text] [Related]
10. Neutrophils are decreased in obsessive-compulsive disorder: preliminary investigation. Atmaca M; Kilic F; Koseoglu F; Ustundag B Psychiatry Investig; 2011 Dec; 8(4):362-5. PubMed ID: 22216047 [TBL] [Abstract][Full Text] [Related]
12. Seasonal mood changes in patients with obsessive-compulsive disorder. Tan O; Metin B; Ünsalver BÖ; Sayar GH Psychiatry Res; 2017 Dec; 258():166-170. PubMed ID: 27979316 [TBL] [Abstract][Full Text] [Related]
13. Reliability and validity of the Thai version of the Yale-Brown Obsessive Compulsive Scale - Second Edition in clinical samples. Hiranyatheb T; Saipanish R; Lotrakul M Neuropsychiatr Dis Treat; 2014; 10():471-7. PubMed ID: 24648741 [TBL] [Abstract][Full Text] [Related]
14. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra. Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787 [TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of the Thai self-report version of the Yale-Brown Obsessive-Compulsive Scale-Second Edition. Hiranyatheb T; Saipanish R; Lotrakul M; Prasertchai R; Ketkaew W; Jullagate S; Udomsubpayakul U; Kusalaruk P Neuropsychiatr Dis Treat; 2015; 11():2817-24. PubMed ID: 26604766 [TBL] [Abstract][Full Text] [Related]
16. Electrical stimulation of the inferior thalamic peduncle in the treatment of major depression and obsessive compulsive disorders. Jiménez F; Nicolini H; Lozano AM; Piedimonte F; Salín R; Velasco F World Neurosurg; 2013; 80(3-4):S30.e17-25. PubMed ID: 22824558 [TBL] [Abstract][Full Text] [Related]
17. Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition. Storch EA; Rasmussen SA; Price LH; Larson MJ; Murphy TK; Goodman WK Psychol Assess; 2010 Jun; 22(2):223-32. PubMed ID: 20528050 [TBL] [Abstract][Full Text] [Related]
18. Criterion Validity of the Yale-Brown Obsessive-Compulsive Scale Second Edition for Diagnosis of Obsessive-Compulsive Disorder in Adults. Castro-Rodrigues P; Camacho M; Almeida S; Marinho M; Soares C; Barahona-Corrêa JB; Oliveira-Maia AJ Front Psychiatry; 2018; 9():431. PubMed ID: 30254588 [No Abstract] [Full Text] [Related]
19. [Hungarian translation of the Dimensional Yale-Brown Obsessive-Compulsive Scale and our first experiences with the test]. Harsányi A; Csigó K; Demeter G; Rajnai C; Németh A; Racsmány M Psychiatr Hung; 2009; 24(1):18-59. PubMed ID: 19542567 [TBL] [Abstract][Full Text] [Related]
20. Serum Lipids among Drug Naïve or Drug-Free Patients with Obsessive Compulsive Disorder and their Association with Impulsivity: A Comparative Study. Vats P; Das B; Khanra S Indian J Psychol Med; 2020; 42(3):281-289. PubMed ID: 32612334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]